Table 1.
First Author | Year | Number of Studies | Inclusion Criteria | Main Outcomes |
---|---|---|---|---|
HU et al3 | 2021 | 12 | Studies evaluating the incidence of VTE, DVT, and PE in RA patients | OR of DVT in RA patients relative to controls: (2.25, 95% CI: 1.70 to 2.98, p<0.001) OR of PE in RA patients relative to controls (2.15, 95% CI: 1.39 to 3.49, p=0.001). OR of VTE in RA patients relative to controls (2.23, 95% CI: 1.79 to 2.77, p<0.001) |
Lee and Pope.55 | 2014 | 10 | Studies evaluating the incidence of VTE, DVT, and PE in RA patients | OR of DVT in RA patients relative to controls: 2.23 (95% CI: 2.02 to 2.47) Cumulative incidence of VTE is 2.18% (95% CI:1.82% to 2.54%) |
Ungprasert et al2 | 2014 | 9 | Observational studies (case-control, cross-sectional, cohort) evaluating the association between RA and VTE, DVT or PE | Pooled risk ratio for VTE 1.96 (95% CI 1.81–2.11) Pooled risk ratio for DVT= 2.08 (95% CI 1.75–2.47) Pooled risk ratio for PE= 2.17 (95% CI 2.05–2.31) |
Abbreviations: RA, rheumatoid arthritis; VTE, venous thromboembolism; DVT, deep venous thrombosis; PE, pulmonary embolism; CI, confidence interval; OR, odds ratio.